Drug Shortage Report for INSPRA
| Report ID | 27636 |
| Drug Identification Number | 02323052 |
| Brand name | INSPRA |
| Common or Proper name | INSPRA |
| Company Name | BGP PHARMA ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | EPLERENONE |
| Strength(s) | 25MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 3x10 Tabs |
| ATC code | C03DA |
| ATC description | POTASSIUM-SPARING AGENTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2017-12-15 |
| Estimated end date | |
| Actual end date | 2018-04-16 |
| Shortage status | Resolved |
| Updated date | 2018-04-17 |
| Company comments | Additional inventory anticipated to be available by April 13th which is expected to fulfill current market demand. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v23 | 2018-04-17 | French | Compare |
| v22 | 2018-04-17 | English | Compare |
| v21 | 2018-04-17 | English | Compare |
| v20 | 2018-04-17 | English | Compare |
| v19 | 2018-04-16 | French | Compare |
| v18 | 2018-04-16 | English | Compare |
| v17 | 2018-03-28 | French | Compare |
| v16 | 2018-03-28 | English | Compare |
| v15 | 2018-02-07 | French | Compare |
| v14 | 2018-02-07 | English | Compare |
| v13 | 2018-01-22 | French | Compare |
| v12 | 2018-01-22 | English | Compare |
| v11 | 2017-12-16 | English | Compare |
| v10 | 2017-12-14 | French | Compare |
| v9 | 2017-12-14 | English | Compare |
| v8 | 2017-12-14 | English | Compare |
| v7 | 2017-11-21 | French | Compare |
| v6 | 2017-11-21 | English | Compare |
| v5 | 2017-11-16 | English | Compare |
| v4 | 2017-11-15 | French | Compare |